Cargando…
Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease
Extracellular vesicles (EVs) play key roles in glioblastoma (GBM) biology and represent novel sources of biomarkers that are detectable in the peripheral circulation. Despite this notionally non-invasive approach to assess GBM tumours in situ, a comprehensive GBM EV protein signature has not been de...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5306193/ https://www.ncbi.nlm.nih.gov/pubmed/27770278 http://dx.doi.org/10.1007/s11060-016-2298-3 |
_version_ | 1782507148818776064 |
---|---|
author | Mallawaaratchy, Duthika M. Hallal, Susannah Russell, Ben Ly, Linda Ebrahimkhani, Saeideh Wei, Heng Christopherson, Richard I. Buckland, Michael E. Kaufman, Kimberley L. |
author_facet | Mallawaaratchy, Duthika M. Hallal, Susannah Russell, Ben Ly, Linda Ebrahimkhani, Saeideh Wei, Heng Christopherson, Richard I. Buckland, Michael E. Kaufman, Kimberley L. |
author_sort | Mallawaaratchy, Duthika M. |
collection | PubMed |
description | Extracellular vesicles (EVs) play key roles in glioblastoma (GBM) biology and represent novel sources of biomarkers that are detectable in the peripheral circulation. Despite this notionally non-invasive approach to assess GBM tumours in situ, a comprehensive GBM EV protein signature has not been described. Here, EVs secreted by six GBM cell lines were isolated and analysed by quantitative high-resolution mass spectrometry. Overall, 844 proteins were identified in the GBM EV proteome, of which 145 proteins were common to EVs secreted by all cell lines examined; included in the curated EV compendium (Vesiclepedia_559; http://microvesicles.org). Levels of 14 EV proteins significantly correlated with cell invasion (invadopodia production; r(2) > 0.5, p < 0.05), including several proteins that interact with molecules responsible for regulating invadopodia formation. Invadopodia, actin-rich membrane protrusions with proteolytic activity, are associated with more aggressive disease and are sites of EV release. Gene levels corresponding to invasion-related EV proteins showed that five genes (annexin A1, actin-related protein 3, integrin-β1, insulin-like growth factor 2 receptor and programmed cell death 6-interacting protein) were significantly higher in GBM tumours compared to normal brain in silico, with common functions relating to actin polymerisation and endosomal sorting. We also show that Cavitron Ultrasonic Surgical Aspirator (CUSA) washings are a novel source of brain tumour-derived EVs, demonstrated by particle tracking analysis, TEM and proteome profiling. Quantitative proteomics corroborated the high levels of proposed invasion-related proteins in EVs enriched from a GBM compared to low-grade astrocytoma tumour. Large-scale clinical follow-up of putative biomarkers, particularly the proposed survival marker annexin A1, is warranted. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11060-016-2298-3) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5306193 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-53061932017-02-24 Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease Mallawaaratchy, Duthika M. Hallal, Susannah Russell, Ben Ly, Linda Ebrahimkhani, Saeideh Wei, Heng Christopherson, Richard I. Buckland, Michael E. Kaufman, Kimberley L. J Neurooncol Laboratory Investigation Extracellular vesicles (EVs) play key roles in glioblastoma (GBM) biology and represent novel sources of biomarkers that are detectable in the peripheral circulation. Despite this notionally non-invasive approach to assess GBM tumours in situ, a comprehensive GBM EV protein signature has not been described. Here, EVs secreted by six GBM cell lines were isolated and analysed by quantitative high-resolution mass spectrometry. Overall, 844 proteins were identified in the GBM EV proteome, of which 145 proteins were common to EVs secreted by all cell lines examined; included in the curated EV compendium (Vesiclepedia_559; http://microvesicles.org). Levels of 14 EV proteins significantly correlated with cell invasion (invadopodia production; r(2) > 0.5, p < 0.05), including several proteins that interact with molecules responsible for regulating invadopodia formation. Invadopodia, actin-rich membrane protrusions with proteolytic activity, are associated with more aggressive disease and are sites of EV release. Gene levels corresponding to invasion-related EV proteins showed that five genes (annexin A1, actin-related protein 3, integrin-β1, insulin-like growth factor 2 receptor and programmed cell death 6-interacting protein) were significantly higher in GBM tumours compared to normal brain in silico, with common functions relating to actin polymerisation and endosomal sorting. We also show that Cavitron Ultrasonic Surgical Aspirator (CUSA) washings are a novel source of brain tumour-derived EVs, demonstrated by particle tracking analysis, TEM and proteome profiling. Quantitative proteomics corroborated the high levels of proposed invasion-related proteins in EVs enriched from a GBM compared to low-grade astrocytoma tumour. Large-scale clinical follow-up of putative biomarkers, particularly the proposed survival marker annexin A1, is warranted. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11060-016-2298-3) contains supplementary material, which is available to authorized users. Springer US 2016-10-21 2017 /pmc/articles/PMC5306193/ /pubmed/27770278 http://dx.doi.org/10.1007/s11060-016-2298-3 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Laboratory Investigation Mallawaaratchy, Duthika M. Hallal, Susannah Russell, Ben Ly, Linda Ebrahimkhani, Saeideh Wei, Heng Christopherson, Richard I. Buckland, Michael E. Kaufman, Kimberley L. Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease |
title | Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease |
title_full | Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease |
title_fullStr | Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease |
title_full_unstemmed | Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease |
title_short | Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease |
title_sort | comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease |
topic | Laboratory Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5306193/ https://www.ncbi.nlm.nih.gov/pubmed/27770278 http://dx.doi.org/10.1007/s11060-016-2298-3 |
work_keys_str_mv | AT mallawaaratchyduthikam comprehensiveproteomeprofilingofglioblastomaderivedextracellularvesiclesidentifiesmarkersformoreaggressivedisease AT hallalsusannah comprehensiveproteomeprofilingofglioblastomaderivedextracellularvesiclesidentifiesmarkersformoreaggressivedisease AT russellben comprehensiveproteomeprofilingofglioblastomaderivedextracellularvesiclesidentifiesmarkersformoreaggressivedisease AT lylinda comprehensiveproteomeprofilingofglioblastomaderivedextracellularvesiclesidentifiesmarkersformoreaggressivedisease AT ebrahimkhanisaeideh comprehensiveproteomeprofilingofglioblastomaderivedextracellularvesiclesidentifiesmarkersformoreaggressivedisease AT weiheng comprehensiveproteomeprofilingofglioblastomaderivedextracellularvesiclesidentifiesmarkersformoreaggressivedisease AT christophersonrichardi comprehensiveproteomeprofilingofglioblastomaderivedextracellularvesiclesidentifiesmarkersformoreaggressivedisease AT bucklandmichaele comprehensiveproteomeprofilingofglioblastomaderivedextracellularvesiclesidentifiesmarkersformoreaggressivedisease AT kaufmankimberleyl comprehensiveproteomeprofilingofglioblastomaderivedextracellularvesiclesidentifiesmarkersformoreaggressivedisease |